Evidence map›Paper›PMID 33650691›Full record

ArticleStatistics in medicine2021

Comparative poisson clinical trials of multiple experimental treatments vs a single control using the negative multinomial distribution.

Joseph A Chiarappa, Donald R Hoover

Abstract read
In one paragraph

Article in Statistics in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joseph A ChiarappaMerck and Co. Inc., North Wales, Pennsylvania, USA.ORCID 0000-0002-1167-0259
Donald R HooverDepartment of Statistics and the Institute for Health, Health Care Policy and Aging Research, Rutgers University, Piscataway, New Jersey, USA.

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Reducing urban women's HIV risk: Soap opera videos streamed to mobile devicesR01NR014632 · NINR · NORTHEASTERN UNIVERSITY · PI JONES, RACHEL · 2015 to 2018
$2.0M
Acute Effects of Cannabis on Cognition and Mobility in Older HIV-Infected and Uninfected Women"R21AG059505 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHARMA, ANJALI · 2018 to 2019
$318k
NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI096299NIA NIH HHS R21 AG059505NINR NIH HHS R01 NR014632
6 · The paper itself

Abstract

This paper introduces a method which conditions on the number of events that occur in the control group to determine rejection regions and power for comparative Poisson trials with multiple experimental treatment arms that are each compared to one control arm. This leads to the negative multinomial as the statistical distribution used for testing. For one experimental treatment and one control with curtailed sampling, this is equivalent to Gail's (1974) approach. We provide formulas to calculate exact one-sided overall Type I error and pointwise power for tests of treatment superiority and inferiority (vs the control). Tables of trial design parameters for combinations of one-sided overall Type I error = 0.05, 0.01 and pointwise power = 0.90, 0.80 are provided. Curtailment approaches are presented to stop follow-up of experimental treatment arms or to stop the study entirely once the final outcomes for each arm are known.

Indexed as

Research DesignHumansStatistical Distributionsclinical trialscomparative Poissonnegative multinomialtreatment inferioritytreatment superiority

Identifiers

PMID33650691
PMCPMC8991471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.